|University of Michigan, Bachelor|
|Cellular and Molecular Biology and Economics|
Jim is General Partner of Deerfield Management, one of the largest dedicated healthcare investment organizations, with over $3 billion in assets invested in over 150 companies whose activities span the spectrum of healthcare-related activities. Jim worked in biotechnology and pharmaceutical equity research at Kidder, Peabody & Co., and was Vice President of Corporate Development at Alpharma (a mid-sized pharmaceutical company with substantial U.S. and International operations), where he completed licensing transactions and managed the company’s strategic review and planning process involving manufacturing, product development, and sales and marketing.
He was a Managing Director at Furman Selz covering pharmaceutical and medical device industries, had a proprietary trading account and was the firm’s top ranked analyst. Since assuming full investment management responsibility at Deerfield in 2005, the firm has grown from 16 to over 45 employees and expanded its capabilities to invest across the capital structure. In 2007 Jim launched Deerfield’s Private Design Fund to provide alternative financing options to healthcare companies.
Deerfield has provided over $500 million in capital commitments through uniquely developed structures. Jim has degrees in Cellular and Molecular Biology and Economics from the University of Michigan.